Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?
Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;
Ann Hepatol. 2023;28:
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
Ankoor H. Patel; Gaurav N. Pathak; Alexander Chen; Patricia Greenberg; Natale Mazzaferro; Anish Patel; Naveen Mallangada; Carlos D. Minacapelli; Kaitlyn Catalano; Hansel Suthar; Vinod K. Rustgi;
10.1016/j.aohep.2024.101510